Global Molecular Diagnostic Point of Care Market to Reach $6.02 Billion by 2029
Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global molecular diagnostic point of care market? • What are the factors resulting in the emerging trends within the global molecular diagnostic point of care market? • How is each segment of the global molecular diagnostic point of care market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029? • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029? • What are the key applications in the global molecular diagnostic point of care market? What are the major segments of these applications? • Who are the key manufacturers the global molecular diagnostic point of care products, and what are their contributions? Global Molecular Diagnostic Point of Care Market Forecast, 2019-2029
The global molecular diagnostic point of care industry analysis projects the market to grow at a significant CAGR of 12.14% during the forecast period, 2019-2029. The molecular diagnostic point of care market generated $1,689.6 million revenue in 2018, in terms of value.
The molecular diagnostic point of care market growth has been primarily attributed to the major drivers in this market such as highly increasing global prevalence of infectious diseases and various types of cancer, growing demand for non-invasive diagnostics, increase in adoption of personalized medicines on a global level, and significant external funding for executing research and development exercises. The challenges include an uncertain reimbursement scenario, a lack of high-complexity testing centers, and high capital requirement hampering the global reach.
“There is no doubt that near-patient molecular testing represents the future of diagnosing infectious diseases, especially those like influenza that are highly transmissible.”
Scope of the Market Intelligence on Global Molecular Diagnostic Point of Care Market
The molecular diagnostic point of care research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.
The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the diagnostic market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global molecular diagnostic point of care market. Market Segmentation
The molecular diagnostic point of care market is segmented into infectious disease, oncology, prenatal testing and other applications, on the basis of application.
The molecular diagnostic point of care market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology and other methods, on the basis of technology.
The molecular diagnostic point of care market is segmented into assays, systems and software, on the basis of type.
The molecular diagnostic point of care market is segmented into hospitals, clinics, diagnostic centers, and other end-users, on the basis of end-user.
The molecular diagnostic point of care market is segmented into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World, on the basis of geography.
Key Companies in the Molecular Diagnostic Point of Care Market
The key manufacturers who have been contributing significantly to the molecular diagnostic point of care market include Hologic, Inc., Abbott Laboratories, bioMerieux S.A., QIAGEN N.V., Quidel Corporation, Biocartis NV, Danaher Corporation, DiaSorin S.p.A., F. Hoffman-La Roche Ltd., Luminex Corporation, Mesa Biotech, QuantuMDx Group Ltd., Spartan Biosciences Inc., DxNA LLC, and Abacus Diagnostica Oy, among others.
Countries Covered • North America • U.S. • Canada • Europe • Germany • U.K. • France • Italy • Spain • The Netherlands • Rest-of-Europe • Asia-Pacific • China • Japan • India • Australia • Singapore • Rest-of-APAC • Latin America • Brazil • Mexico • Rest-of-Latin America • Rest-of-the-World
Our reports have been used by over 10K customers, including:
Point of Care (PoC) Molecular Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Point of Care (PoC) Molecular Diagnostics market including...
G-protein coupled receptors market is anticipated to be driven by rising number of cancer cases, rising prevalence of lifestyle-related issues, such as cardiovascular infections, and respiratory issues. G-protein coupled receptors (GPCRs) are exceptionally helpful in the innovative work of newer medication substances. Furthermore, the increasing...
The Digital PCR market is projected to register a CAGR of nearly 17.8% over the forecast period. The major factor attributing to the growth of the market is the rising diagnostics and screening tests of diseases like cancer, hereditary, and infectious diseases, and the growing demand for parental testing and gene study. As per GLOBOCAN, the...
The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding...
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical...
Cell-based Assay Market Research Report by Offerings (Consumables, Instruments, and Services), by Application (Basic Research and Drug Discovery), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Cell-based Assay Market is expected to grow from USD 12,722.49 Million in 2019 to USD 18,467.21...
Molecular Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Molecular Diagnostics market including the COVID-19 pandemic implications...
Endocrinology Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Endocrinology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.